ALMSNasdaqPharmaceutical PreparationsFiscal year ends December 31
ALUMIS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$6.34+0.22 (+3.59%)
Close on Oct 19, 2026
- Market cap
- $809.56M
- P/E (TTM)
- –
- Dividend yield
- –
Alumis statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Alumis | Industry median |
|---|---|---|
| Market Cap | $820.62M | $197.05M |
| Enterprise Value | $318.32M | $106.56M |
| PS Ratio | 110.92 | 3.93 |
| PB Ratio | 1.81 | 2.14 |
| P/TBV Ratio | 1.81 | 2.46 |
Enterprise value
| Measure | Alumis | Industry median |
|---|---|---|
| EV / Sales | 43.03 | 2.69 |
Income (trailing twelve months)
| Measure | Alumis | Industry median |
|---|---|---|
| Revenue | $7.40M | $57.94M |
| Operating Income | -$459.00M | -$21.44M |
| Net Income | -$438.96M | -$22.46M |
| EBITDA | -$455.56M | -$16.91M |
| EPS (Diluted) | -$3.80 | -$0.83 |
Margins
| Measure | Alumis | Industry median |
|---|---|---|
| Operating Margin | -6204.4% | -44.5% |
| Profit Margin | -5933.4% | -39.2% |
| EBITDA Margin | -6157.9% | -31.3% |
| FCF Margin | -4755.3% | -8.85% |
Returns
| Measure | Alumis | Industry median |
|---|---|---|
| Return on Equity (ROE) | -93.6% | -53.1% |
| Return on Assets (ROA) | -74.9% | -41.0% |
| Return on Capital Employed (ROCE) | -94.8% | -37.8% |
Balance sheet
| Measure | Alumis | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $502.30M | $62.42M |
| Net Cash (Debt) | $502.30M | $15.68M |
| Net Cash Per Share | $3.88 | $0.65 |
| Equity (Book Value) | $452.16M | $48.79M |
| Book Value Per Share | $3.49 | $1.36 |
| Tangible Book Value | $452.16M | $23.06M |
| Working Capital | $437.85M | $75.77M |
Financial position
| Measure | Alumis | Industry median |
|---|---|---|
| Current Ratio | 6.74 | 3.30 |
| Quick Ratio | 6.59 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Alumis | Industry median |
|---|---|---|
| Operating Cash Flow | -$351.40M | -$12.35M |
| Capital Expenditures | -$401.00K | -$1.06M |
| Free Cash Flow | -$351.80M | -$20.28M |
| FCF Per Share | -$2.72 | -$0.41 |
Efficiency
| Measure | Alumis | Industry median |
|---|---|---|
| Asset Turnover | 0.01 | 0.38 |
| Revenue Per Employee | $43.52K | $398.96K |
| Profits Per Employee | -$2.58M | -$732.08K |
| Employee Count | 170 | 73 |
Dividends and yields
| Measure | Alumis | Industry median |
|---|---|---|
| Earnings Yield | -53.5% | -21.2% |
| FCF Yield | -42.9% | -7.64% |
Shares
| Measure | Alumis | Industry median |
|---|---|---|
| Shares Outstanding | 129,435,000 | 59,128,900 |
| Shares Change (YoY) | 84.4% | 11.1% |
| Float | 89,912,300 | 48,744,500 |
| Shares Held by Insiders | 30.5% | 11.8% |
| Shares Held by Institutions | 91.3% | 59.4% |
Scores
| Measure | Alumis | Industry median |
|---|---|---|
| Altman Z-Score | -0.05 | 0.10 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Alumis's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.